Simponi injection vs. Simponi Aria infusion Simponi comes as a liquid solution inside single-use, prefilled auto-injector pens and syringes. You or a caregiver will inject Simponi under your skin .

Don’t give Simponi injections into skin that’s bruised, hard, damaged, scarred, or tender. For Simponi Aria, your doctor will monitor you during the infusion.

Golimumab is available either through the SmartJect ® autoinjector/prefilled pen or a prefilled syringe as a ... 5.1 percent of SIMPONI treated patients had injection site reactions compared with ...

SIMPONI is available either through the SmartJect® autoinjector/prefilled pen or a prefilled syringe as a subcutaneously administered injection. For more information about SIMPONI in the United ...

Simponi Aria (golimumab) Injection is a colorless to light yellow solution available in packs of 1 vial. Each single-dose vial contains 50 mg of Simponi Aria per 4 mL of solution.

J&J is pulling at least 395 injection pens in the U.S. and Germany that are pre-loaded with Simponi, a rheumatoid-arthritis drug Skip to Main Content Explore Our Brands ...

Simponi is given by subcutaneous injection using the available prefilled syringe or SmartJect auto-injector. (You may be able to self-inject the drug at home after your doctor shows you how.) ...

Furthering its recall woes, Johnson & Johnson ($JNJ) is removing about 400 of its Simponi injection pens from the U.S. and German markets due to a manufacturing flaw ...

Johnson & Johnson has recalled lots of its Simponi injections for possible substandard dosage of its arthritis treatment, according to a Reuters news report. A Johnson & Johnson spokesperson said ...

Janssen Biotech announced data from three Phase 3 trials, GO-FORWARD, GO-BEFORE, and GO-AFTER evaluating Simponi 50mg administered subcutaneously once every four weeks in the treatment of ...

Johnson & Johnson recalled injectors filled with its Simponi arthritis treatment in the U.S. and Germany and withheld shipments, adding to glitches that cost the company more than $900 million ...